Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Pulmonary Aspiration Warning Added to Ozempic, Wegovy, Mounjaro and Other GLP-1s Regarding Use Before Anesthesia or Deep Sedation New GLP-1 warnings will urge users to inform their doctors before surgery if they are taking the diabetes and weight loss drugs. November 7, 2024 Irvin Jackson Add Your Comments Federal regulators have added new warnings to Ozempic, Wegovy, Mounjaro and similar drugs that are part of a class of medications known as glucagon-like peptide-1 receptor agonists (GLP-1s), indicating that the popular diabetes and weight loss treatments have been linked to incidents of pulmonary aspiration among patients undergoing elective surgeries. The American Society of Anesthesiologists (ASA) first warned about the surgical risk of pulmonary aspiration from Ozempic in July 2023, when it issued guidance for the medical community about the importance of patients stopping use of GLP-1 medications before elective surgery. Since the medications work by delaying gastric emptying, the group warned that users may be prone to vomit and aspirate while under anesthesia, which could lead to life-threatening surgical complications. However, information about the GLP-1 pulmonary aspiration risk was not included on the warning labels for Ozempic, Wegovy and other widely used drugs in this class, until now. Find Out If You Have a Lawsuit Were you prescribed Ozempic, Wegovy or Mounjaro? Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects Learn More SEE IF YOU QUALIFY FOR COMPENSATION Find Out If You Have a Lawsuit Were you prescribed Ozempic, Wegovy or Mounjaro? Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects Learn More SEE IF YOU QUALIFY FOR COMPENSATION On November 1, the U.S. Food and Drug Administration (FDA) issued a drug safety label update for the entire class of medications, adding new information to the “Warnings and Precautions” section of Ozempic, Mounjaro, Zepbound, Wegovy, Rybelsus, Saxenda, Trulicity, Byetta and Victoza. “There have been rare postmarketing reports of pulmonary aspiration in patients receiving GLP-1 receptor agonists undergoing elective surgeries or procedures requiring general anesthesia or deep sedation who had residual gastric contents despite reported adherence to preoperative fasting recommendations,” the new labels will indicate. “Available data are insufficient to inform recommendations to mitigate the risk of pulmonary aspiration during general anesthesia or deep sedation in patients taking Ozempic, including whether modifying preoperative fasting recommendations or temporarily discontinuing Ozempic could reduce incidents of retained gastric contents.” Under the “Medication Guide” section of the drug labels, the FDA urges patients to inform their healthcare providers that they are taking a GLP-1 drug before going in for surgery or other medical procedures. However, doctors are also being urged to tell patients about the risks of pulmonary aspiration during surgery when the medications are prescribed, and instruct them to inform healthcare providers before any planned procedures. GLP-1 Stomach Paralysis Lawsuits The new GLP-1 pulmonary aspiration warnings come as the manufacturers already face hundreds of Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits, each raising similar allegations that users and the medical community were not adequately warned about serious risks that may result from delayed gastric emptying caused by the medications. Most of the lawsuits involve claims that former users were left with gastroparesis from Ozempic or other GLP-1 medications, which involves complete stomach paralysis that impedes the movement of stomach muscles, resulting in persistent vomiting, hospitalization and other long-term health outcomes. Given common questions of fact and law raised in the claims, all federal GLP-1 lawsuits have been centralized as part of an MDL, or multidistrict litigation, where U.S. District Judge Karen S. Marston is overseeing coordinated discovery and pretrial proceedings. The court is currently focusing early discovery and motions practice on a series of “cross cutting” issues that impact all claims, including an evaluation of general causation, pre-emption and whether specific gastroparesis testing is needed in the lawsuits. Following rulings on early motions that may limit the size and scope of the litigation, it is expected that Judge Marston will schedule a series of early bellwether test trials, to help the parties gauge how juries may respond to expert testimony and evidence that will likely be repeated throughout hundreds of pending lawsuits. While the outcomes of such early test trials are not binding on other claims, they are often critical to help the parties gauge how juries are likely to respond to certain evidence and testimony that will be repeated throughout the litigation, potentially facilitating Ozempic settlement negotiations that would avoid the need for each individual case to be set for trial in the future. Tags: Anesthesia, Byetta, Diabetes, Diabetes Drugs, Gastrointestinal, Gastroparesis, Mounjaro, Novo Nordisk, Ozempic, Stomach Paralysis, Surgery, Trulicity, Wegovy, Weight Loss Image Credit: Shutterstock: Marc Bruxelle Find Out If You Qualify for Ozempic or Wegovy Compensation More Ozempic, Wegovy and Mounjaro Lawsuit Stories Ozempic Vision Risks Could Also Include Age-Related Macular Degeneration: Study June 23, 2025 Centralization of Ozempic, Wegovy NAION Lawsuits Sought in New Jersey State Court June 18, 2025 Saxenda, Wegovy Vision Loss Lawsuit Filed Over NAION Diagnosis June 13, 2025 1 Comments Stefan November 10, 2024 I was taking Ozempic for almost a year and had to have my gallbladder taken out due to sideffects that i suffered from it. Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Link Between Hair Relaxers and Cancer To Be Examined by Court During “Science Day” (Posted: yesterday) A federal judge has called for Science Day presentations to explain to the court the theories and evidence linking hair relaxer to increased cancer risks. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Cancer Lawsuits Continue To Be Filed as Lawyers Prepare First Cases for Trial (06/24/2025)Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (06/12/2025)Hair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025) Lawyers Ordered To Engage in Talcum Powder Settlement Talks in MDL (Posted: yesterday) A special mediator has been appointed to oversee negotiations between Johnson & Johnson and tens of thousands of women who say its talcum powder products caused them to develop reproductive system cancers. MORE ABOUT: TALCUM POWDER LAWSUITSTalcum Powder Ovarian Cancer Lawsuit Selected for First Federal Bellwether Trial (07/01/2025)Retired Talcum Powder Judge May Be Appointed To Address Renewed Expert Motions (06/20/2025)Talc Safety To Be Subject of New Independent Scientific Expert Panel Led by FDA (05/22/2025) Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (Posted: 2 days ago) A wrongful death lawsuit claims a woman’s sister died of a Depo-Provera brain tumor which was not discovered until after her death. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)
Link Between Hair Relaxers and Cancer To Be Examined by Court During “Science Day” (Posted: yesterday) A federal judge has called for Science Day presentations to explain to the court the theories and evidence linking hair relaxer to increased cancer risks. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Cancer Lawsuits Continue To Be Filed as Lawyers Prepare First Cases for Trial (06/24/2025)Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (06/12/2025)Hair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025)
Lawyers Ordered To Engage in Talcum Powder Settlement Talks in MDL (Posted: yesterday) A special mediator has been appointed to oversee negotiations between Johnson & Johnson and tens of thousands of women who say its talcum powder products caused them to develop reproductive system cancers. MORE ABOUT: TALCUM POWDER LAWSUITSTalcum Powder Ovarian Cancer Lawsuit Selected for First Federal Bellwether Trial (07/01/2025)Retired Talcum Powder Judge May Be Appointed To Address Renewed Expert Motions (06/20/2025)Talc Safety To Be Subject of New Independent Scientific Expert Panel Led by FDA (05/22/2025)
Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (Posted: 2 days ago) A wrongful death lawsuit claims a woman’s sister died of a Depo-Provera brain tumor which was not discovered until after her death. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)